Milap Nowrangi, M.D., MS, is an assistant professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine. Dr. Nowrangi specializes in the diagnosis and treatment of age-related cognitive disorders, including Alzheimer's Disease and related dementias. He also is interested in the treatment or management of behavioral and cognitive sequelae of neurological diseases, including those caused by traumatic brain injury, stroke, epilepsy or toxic exposures. Dr. Nowrangi is rated as a Distinguished provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Alzheimer's Disease, Dementia, Bipolar Disorder (BPD), and Neuronal Intranuclear Inclusion Disease (NIID).

A native of Athens, Greece, Professor Lyketsos graduated from Northwestern University with a BA in Psychology and from Washington University Medical School in St. Louis with a Medical Doctorate. He completed residency and Chief Residency in psychiatry at Johns Hopkins, as well as a fellowship in clinical epidemiology. An active clinician, teacher, and researcher, Dr. Lyketsos is a world expert in the care and treatment of patients with Alzheimer’s and related dementias (ADRD). He carried out pioneering work on the epidemiology and treatment of neuropsychiatric features of AD. His team is developing biomarkers to accelerate treatment development for AD while designing and implementing innovative clinical trials. He leads efforts to ensure the provision of state-of-the-art Dementia Care for people with dementia in the community. Dr. Lyketsos is the Elizabeth Plank Althouse Professor at Johns Hopkins University. He directs the Johns Hopkins Bayview Department of Psychiatry and Behavioral Sciences, as well as the Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease and the Memory and Alzheimer’s Treatment Center. He is the recipient of multiple awards including the 2022 Argo Award for Science from the President of the Hellenic Republic. He has authored/co-authored over 450 peer-reviewed articles, chapters, commentaries, as well as five books. His work has been cited over 76,000 times with an h-index of 149. A 2021 Stanford University publication reported that he ranked #13 out of 9,246 scientists worldwide (all-time) in the field of Geriatrics. Castle-Connolly has named Dr. Lyketsos as one of America’s Top Doctors every year since 2001. A listing of Dr. Lyketsos’ publications can be found at: https://www.ncbi.nlm.nih.gov/myncbi/constantine.lyketsos.1/bibliography/public/. Dr. Lyketsos is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Dementia, Alzheimer's Disease, Lewy Body Dementia (LBD), Cerebellar Degeneration, and Deep Brain Stimulation.

James Bernheimer is a Neurologist in Baltimore, Maryland. Dr. Bernheimer is rated as an Advanced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Opsoclonus-Myoclonus Syndrome, Peripheral Neuropathy, Benign Rolandic Epilepsy, and Myasthenia Gravis.

Dr. Halima Amjad is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her clinical expertise in geriatric medicine focuses on the diagnosis, treatment, and care for individuals living with dementia. Dr. Amjad earned her M.D. and Master’s of Public Health from Drexel University. She completed her residency and chief residency in internal medicine at Yale-New Haven Hospital and a fellowship in geriatric medicine and gerontology at Johns Hopkins University School of Medicine. She joined the faculty of Johns Hopkins in 2016. She completed a PhD in Clinical Investigation at the Johns Hopkins University Bloomberg School of Public Health in 2022. She conducts health services research focuses on informing and improving the care of older adults with dementia with research into underdiagnosis, hospitalization, and primary care in dementia. Recent News Articles and Media Coverage Doyle K. Older adults with probable dementia often take part in unsafe activities. Reuters, June 3, 2016 Many people who have dementia don’t know it. Here’s who’s most at risk, The Philadelphia Inquirer, July 23, 2018 With cognitive impairment, older adults struggle with — and face risks from — smartphones, computers. Washington Post, (October 13, 2019). Dr. Amjad is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Dementia, Alzheimer's Disease, Cerebellar Degeneration, and Frontotemporal Dementia.

Cynthia Fields is a Psychiatrist and a Geriatrics provider in Lutherville, Maryland. Dr. Fields is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Major Depression, Seasonal Affective Disorder (SAD), Alzheimer's Disease, and Bipolar Disorder (BPD).

Mercy Jackson, M.D., has practiced primary care in the Howard County community for more than 18 years. She received her medical degree from Stanley Medical College in India. Dr. Jackson then completed her residency with Saint Agnes Hospital in Baltimore and completed her intern year with New York Methodist Hospital in Brooklyn, New York. Dr. Jackson's areas of expertise are preventive care, management of chronic conditions and obesity medicine. She treats obesity as a disease and helps her patients in their weight-loss journey in order to prevent chronic illnesses. Over the years she has enjoyed building a relationship and bond with her patients. She has also enjoyed working with like- minded professionals who share her passion to help people take better care of their health. Dr. Jackson is a careful listener and does her very best to help her patients with their medical concerns. She also enjoys participating in community outreach projects like medical camps and medical mission trips. When not with patients, she enjoys spending time with my family, traveling, swimming, biking and being outdoors. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Neuronal Intranuclear Inclusion Disease (NIID).

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy.

Dagmara Pychynski is a Neurologist in Elkton, Maryland. Dr. Pychynski has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Peripheral Neuropathy, and Memory Loss.

1988-1992, Assistant Professor, Department of Pharmacology, Semmelweis Medical University, Budapest, Hungary. 1992-1996, Instructor, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 2001-2014, Assistant Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2012-2014, Assistant Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Associate Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. Dr. Yasar is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Dementia, and Alzheimer's Disease.

Dr. Abhay Moghekar focuses on disorders of cerebrospinal fluid physiology like normal pressure hydrocephalus, obstructive hydrocephalus, congenital hydrocephalus, pseudotumor cerebri, CSF otorhhea, CSF rhinorrhea, intracranial hypotension due to spinal CSF leaks and peri-operative management of patients undergoing repair of CSF otorrhea and rhinorrhea. His research interests include identifying biomarkers of neurodegenerative disorders including Alzheimer's disease and Normal Pressure Hydrocephalus. Dr. Moghekar is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Increased Intracranial Pressure, Hydrocephalus, Pseudotumor Cerebri Syndrome, Stent Placement, and Gastrostomy.

Merrill Ansher is a Neurologist in Columbia, Maryland. Dr. Ansher is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Seizures, Familial Neurocardiogenic Syncope, Delirium, and Generalized Tonic-Clonic Seizure.

Dr. Dulce Cruz-Oliver is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine, geriatrics and palliative medicine. She earned her M.D. from the University of Puerto Rico School of Medicine. She completed her residency in internal medicine at University District Hospital and performed a fellowship at Saint Louis University Hospital. Dr. Cruz-Oliver joined the Johns Hopkins faculty in 2017. Dr. Cruz is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Dementia, Hypertension, Familial Hypertension, Vascular Dementia, and Gastrostomy.

Dr. Peter M. Abadir is a geriatrician and translational researcher at Johns Hopkins University. He serves as the Principal Investigator of the Johns Hopkins Artificial Intelligence and Technology Collaboratory for Aging Research, where he leads interdisciplinary initiatives to advance innovations in aging and resilience science. His clinical focus includes frailty, cognitive decline, and age-related conditions, while his translational research bridges molecular biology, bioengineering, and geriatrics. Dr. Abadir is an Associate Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins School of Medicine and holds a joint appointment in Electrical and Computer Engineering at the Whiting School of Engineering. He also directs the Molecular Measurement Core of the Johns Hopkins Older Americans Independence Center and co-directs the Clinical Translation and Validation Core for the Artificial Intelligence and Technology Collaboratory. He currently serves as Chair of the MD Admissions Committee for the Johns Hopkins School of Medicine, overseeing the selection of the next generation of leaders in medicine. Additionally, Dr. Abadir is the Deputy Editor of the Journal of the American Geriatrics Society and serves on several other journal editorial boards. Among his research contributions, Dr. Abadir was among the first to describe the presence of a mitochondrial angiotensin system, providing new insights into cellular energy metabolism and aging. His pioneering work has also focused on biomarkers for frailty and cognitive decline, including circulating mitochondrial DNA and inflammation-related pathways. Notably, his research on the use tof topical angiotensin system blockers has introduced novel approaches to wound healing in aging populations. Dr. Abadir is a recipient of the Nathan Shock Scholar in Aging Award and the Frederick L. Brancati Excellence in Mentoring Award. Additionally, he has received the Johns Hopkins Institute for Excellence in Education Leadership and Mentorship Award and was inducted into the Johns Hopkins Distinguished Teaching Society, reflecting his outstanding contributions to mentorship and education. Dr. Abadir co-founded the Johns Hopkins Gerotech Incubator Program, which integrates medicine, engineering, and technology to develop solutions that enhance the health and independence of older adults. LinkedInhttps://www.linkedin.com/in/peter-abadir-87401715/. Dr. Abadir is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Dementia, Alzheimer's Disease, Vasoconstriction, and Muscle Atrophy.

Dr. Jee Bang cares for patients with disorders of cognition and movement, such as Huntington disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, dementia with Lewy bodies, frontotemporal dementia, and Alzheimer disease. Dr. Bang is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Supranuclear Ocular Palsy, and Progressive Supranuclear Palsy.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Godswill Okoji is a primary care provider, practicing in Family Medicine in Hyattsville, Maryland. Dr. Okoji is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, End-Stage Renal Disease (ESRD), and Gastrostomy.

Dimitrios Kapogiannis is a Neurologist in Baltimore, Maryland. Dr. Kapogiannis is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, and Memory Loss.

Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as an Experienced provider by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). Her top areas of expertise are Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.